Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China

被引:75
作者
Qian, Han-Zhu
Vermund, Sten H.
Kaslow, Richard A.
Coffey, Christopher S.
Chamot, Eric
Yang, Zhongmin
Qiao, Xiaochun
Zhang, Yuliang
Shi, Xiaoming
Jiang, Yan
Shao, Yiming
Wang, Ning [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Naltl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China
[2] Vanderbilt Univ, Med Ctr, Inst Global Hlth, Nashville, TN 37232 USA
[3] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA
[5] Shanxi Prov Ctr Dis Control & Prevent, Taiyuan, Peoples R China
[6] Wenxi Cty Bur Hlth, Shanxi, Peoples R China
关键词
HIV; hepatitis C virus; cross-sectional study; plasma donors; rural health; China;
D O I
10.1097/01.aids.0000233577.33973.fa
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Background: Illegal commercial plasma donation in the late 1980s and early 1990s caused blood-borne infections in China. Objectives: To estimate the prevalence of HIV and hepatitis C virus (HCV) infections and to identify associated risk factors in central China with a history of illegal plasma collection activities. Design and methods: A cross-sectional study was carried out in 2004, in which all adult residents in four villages in rural Shanxi Province were invited for a questionnaire interview and testing of HIV and HCV antibodies. Results: Of 3062 participating villagers, 29.5% reported a history of selling whole blood or plasma. HIV seropositivity was confirmed in 1.3% of subjects and 12.7% were HCV positive. Their co-infection rates were 1.1 % among all study subjects, 85% among HIV-positive subjects, and 8.7% among HCV-positive subjects. Selling plasma [odds ratio (OR), 22.5; 95% confidence interval (CI), 16.1-31.7; P < 0.001] or blood (OR, 3.1; 95% Cl, 2.3-4.2; P < 0.001) were independently associated with HIV and/or HCV infections. Although a spouse's history of selling plasma/blood was not associated with either infection, the HIV or HCV seropositivity of a spouse was significantly associated with HIV and/or HCV infections (both OR, 3.2; 95% Cl, 2.0-5.2 in men, 2.0-4.9 in women; P < 0.001). For men, residence in the village with a prior illegal plasma collection center (OR, 2.5; 95% Cl, 1.7-3.7; P < 0.001) and for women, older age (OR, 3.4; 95% Cl, 1.2-14.0; P = 0.04) were associated with HIV and/or HCV infections. Conclusions: HIV and HCV infections are now prevalent in these Chinese communities. HIV projects should consider screening and care for HCV co-infection. (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:1429 / 1435
页数:7
相关论文
共 26 条
[1]
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].
Benhamou, Y ;
Bochet, M ;
Di Martino, V ;
Charlotte, F ;
Azria, F ;
Coutellier, A ;
Vidaud, M ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (04) :1054-1058
[2]
CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1
[3]
HIGH HEPATITIS-C VIREMIA AND IMPAIRED ANTIBODY-RESPONSE IN PATIENTS COINFECTED WITH HIV [J].
CRIBIER, B ;
REY, D ;
SCHMITT, C ;
LANG, JM ;
KIRN, A ;
STOLLKELLER, F .
AIDS, 1995, 9 (10) :1131-1136
[4]
Coinfection with hepatitis viruses and outcome of initial Antiretroviral regimens in previously naive HIV-Infected subjects [J].
De Luca, A ;
Bugarini, R ;
Lepri, AC ;
Puoti, M ;
Girardi, E ;
Antinori, A ;
Poggio, A ;
Pagano, G ;
Tositti, G ;
Cadeo, G ;
Macor, A ;
Toti, M ;
Monforte, AD .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (18) :2125-2132
[5]
Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection [J].
den Brinker, M ;
Wit, FWNM ;
Wertheim-van Dillen, PME ;
Jurriaans, S ;
Weel, J ;
van Leeuwen, R ;
Pakker, NG ;
Reiss, P ;
Danner, SA ;
Weverling, GJ ;
Lange, JMA .
AIDS, 2000, 14 (18) :2895-2902
[6]
Plasma collection and donor safety in rural China [J].
Dodd, RY .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (10) :1681-1682
[7]
Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests [J].
George, SL ;
Gebhardt, J ;
Klinzman, D ;
Foster, MB ;
Patrick, KD ;
Schmidt, WN ;
Alden, B ;
Pfaller, MA ;
Stapleton, JT .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (02) :154-162
[8]
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study [J].
Greub, G ;
Ledergerber, B ;
Battegay, M ;
Grob, P ;
Perrin, L ;
Furrer, H ;
Burgisser, P ;
Erb, P ;
Boggian, K ;
Piffaretti, JC ;
Hirschel, B ;
Janin, P ;
Francioli, P ;
Flepp, M ;
Telenti, A .
LANCET, 2000, 356 (9244) :1800-1805
[9]
Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: The China integrated programs for research on AIDS [J].
Qian, HZ ;
Yang, ZM ;
Shi, XM ;
Gao, JH ;
Xu, CL ;
Wang, L ;
Zhou, K ;
Cui, Y ;
Zheng, XW ;
Wu, ZY ;
Lu, F ;
Lai, SH ;
Vermund, SH ;
Shao, YM ;
Wang, N .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (10) :1694-1700
[10]
Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS clinical trials group [J].
Sherman, KE ;
Rouster, SD ;
Chung, RT ;
Rajicic, N .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :831-837